<DOC>
	<DOCNO>NCT00290173</DOCNO>
	<brief_summary>This trial compare efficacy oral ritodrine form sustain release capsule maintenance uterine quiescence successfully treat episode threaten preterm labor .</brief_summary>
	<brief_title>Ritodrine Oral Maintenance Tocolysis After Active Preterm Labor</brief_title>
	<detailed_description>We randomize 120 woman singleton pregnancy successfully treat threatened preterm labor 34 complete week receive either maintenance tocolysis two 40 mg ritodrine sustain release capsule three time day ( study group , n=62 ) treatment ( control group , n=58 ) three day . The primary outcome measure recurrent episode threaten preterm labor within 72 hour , define regular palpable uterine contraction change cervical effacement and/or cervical dilatation clinical examination . Secondary outcome measure include incidence preterm birth , neonatal adverse outcome , maternal side effect .</detailed_description>
	<mesh_term>Obstetric Labor , Premature</mesh_term>
	<mesh_term>Ritodrine</mesh_term>
	<criteria>Pregnancy complete 24 24 week Successfully treat episode threaten preterm labour intravenous preparation No uterine contraction Uterine contraction ( painful , clinically palpable , present cardiotocography ) Cervical dilatation ≥5 cm Clinical laboratory sign infection define offensive vaginal discharge clinical examination , vaginal pH ≥5 , white blood cell ( WBC ) count &gt; 16×109/L , Creactive protein ( CRP ) &gt; 10 mg/L Positive finding microorganisms rather normal vaginal flora high vaginal swab Any sign fetal distress accord cardiotocography , Doppler assessment blood flow umbilical artery , biophysical profile &lt; 8 .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2006</verification_date>
	<keyword>pre term labor</keyword>
	<keyword>therapy</keyword>
	<keyword>maintenance</keyword>
</DOC>